206 related articles for article (PubMed ID: 9668502)
21. Culture-derived parasites in vaccination of cattle against tick-borne diseases.
Shkap V; Pipano E
Ann N Y Acad Sci; 2000; 916():154-71. PubMed ID: 11193616
[TBL] [Abstract][Full Text] [Related]
22. Seroprevalence of anaplasmosis and babesiosis in livestock on St Lucia, 1983.
Hugh-Jones ME; Scotland K; Applewhaite LM; Alexander FM
Trop Anim Health Prod; 1988 Aug; 20(3):137-9. PubMed ID: 3194971
[No Abstract] [Full Text] [Related]
23. Exoantigens of an attenuated strain of Babesia bovis used as a vaccine against bovine babesiosis.
Patarroyo JH; Prates AA; Tavares CA; Mafra CL; Vargas MI
Vet Parasitol; 1995 Oct; 59(3-4):189-99. PubMed ID: 8533277
[TBL] [Abstract][Full Text] [Related]
24. Vaccination of cattle against B. bovis infection with live attenuated parasites and non-viable immunogens.
Fish L; Leibovich B; Krigel Y; McElwain T; Shkap V
Vaccine; 2008 Dec; 26 Suppl 6():G29-33. PubMed ID: 19178890
[TBL] [Abstract][Full Text] [Related]
25. Vaccines against hemoparasitic diseases in Israel with special reference to quality assurance.
Pipano E
Trop Anim Health Prod; 1997 Nov; 29(4 Suppl):86S-90S. PubMed ID: 9512751
[TBL] [Abstract][Full Text] [Related]
26. Vaccination against bovine babesiosis.
De Vos AJ; Bock RE
Ann N Y Acad Sci; 2000; 916():540-5. PubMed ID: 11193669
[TBL] [Abstract][Full Text] [Related]
27. Immunisation of cattle against Babesia bovis combining a multi-epitope modified vaccinia Ankara virus and a recombinant protein induce strong Th1 cell responses but fails to trigger neutralising antibodies required for protection.
Jaramillo Ortiz JM; Paoletta MS; Gravisaco MJ; López Arias LS; Montenegro VN; de la Fournière SAM; Valenzano MN; Guillemi EC; Valentini B; Echaide I; Farber MD; Wilkowsky SE
Ticks Tick Borne Dis; 2019 Oct; 10(6):101270. PubMed ID: 31445874
[TBL] [Abstract][Full Text] [Related]
28. Australian frozen vaccines for the control of babesiosis and anaplasmosis in cattle--a review.
Dalgliesh RJ; Jorgensen WK; de Vos AJ
Trop Anim Health Prod; 1990 Feb; 22(1):44-52. PubMed ID: 2181745
[No Abstract] [Full Text] [Related]
29. Vaccination of older Bos taurus bulls against bovine babesiosis.
Shkap V; Leibovitz B; Krigel Y; Hammerschlag J; Marcovics A; Fish L; Molad T; Savitsky I; Mazuz M
Vet Parasitol; 2005 May; 129(3-4):235-42. PubMed ID: 15845278
[TBL] [Abstract][Full Text] [Related]
30. Babesia bovis and B. bigemina: Persistence of infection in friesian cows following vaccination with live antibabesial vaccines.
Pipano E; Shkap V; Kriegel Y; Leibovitz B; Savitsky I; Fish L
Vet J; 2002 Jul; 164(1):64-8. PubMed ID: 12359486
[TBL] [Abstract][Full Text] [Related]
31. Bovine babesiosis and anaplasmosis follow-up on cattle relocated in an endemic area for hemoparasitic diseases.
Figueroa JV; Alvarez JA; Ramos JA; Rojas EE; Santiago C; Mosqueda JJ; Vega CA; Buening GM
Ann N Y Acad Sci; 1998 Jun; 849():1-10. PubMed ID: 9668444
[TBL] [Abstract][Full Text] [Related]
32. Subunit vaccines for complex tick-borne pathogens: dream or reality?
Morrison WI
Br Vet J; 1996 Nov; 152(6):617-9. PubMed ID: 8979420
[No Abstract] [Full Text] [Related]
33. Post-thawing viability of vaccines for bovine babesiosis and anaplasmosis cryopreserved with glycerol.
Mangold AJ; Aguirre DH; Guglielmone AA
Vet Parasitol; 1990 Nov; 37(3-4):301-6. PubMed ID: 2267730
[TBL] [Abstract][Full Text] [Related]
34. Field evaluation of an exoantigen-containing Babesia vaccine in Venezuela.
Montenegro-James S; Toro M; Leon E; Guillen AT
Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():283-8. PubMed ID: 1343704
[TBL] [Abstract][Full Text] [Related]
35. Viability after thawing and dilution of simultaneously cryopreserved vaccinal Babesia bovis and Babesia bigemina strains cultured in vitro.
Mangold AJ; Vanzini VR; Echaide IE; de Echaide ST; Volpogni MM; Guglielmone AA
Vet Parasitol; 1996 Feb; 61(3-4):345-8. PubMed ID: 8720572
[TBL] [Abstract][Full Text] [Related]
36. Bovine babesiosis and anaplasmosis: control by premunition and chemoprophylaxis.
Todorovic RA; Lopez LA; Lopez AG; Gonzalez EF
Exp Parasitol; 1975 Feb; 37(1):92-104. PubMed ID: 1116519
[No Abstract] [Full Text] [Related]
37. [Seroprevalence of babesiosis in cattle in Sivas].
Kalkan K; Ozçelık S; Malatyali E
Turkiye Parazitol Derg; 2010; 34(1):11-6. PubMed ID: 20340080
[TBL] [Abstract][Full Text] [Related]
38. Efficiency of a recombinant MSA-2c-based ELISA to establish the persistence of antibodies in cattle vaccinated with Babesia bovis.
Bono MF; Mangold AJ; Baravalle ME; Valentini BS; Thompson CS; Wilkowsky SE; Echaide IE; Farber MD; Torioni de Echaide SM
Vet Parasitol; 2008 Nov; 157(3-4):203-10. PubMed ID: 18783887
[TBL] [Abstract][Full Text] [Related]
39. Prospects for recombinant vaccines against Babesia bovis and related parasites.
Brown WC; Norimine J; Goff WL; Suarez CE; McElwain TF
Parasite Immunol; 2006 Jul; 28(7):315-27. PubMed ID: 16842268
[TBL] [Abstract][Full Text] [Related]
40. Estimation of the potential demand for a bovine babesiosis and anaplasmosis vaccine in Argentina.
Späth EJ; Mangold AJ; Guglielmone AA
Vet Parasitol; 1990 May; 36(1-2):131-40. PubMed ID: 2382381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
